Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole in acute schizophrenia episode
NCT03289026Phase 4Completed
- Sponsor
- Peking University
- Start
- Sep 2017
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, sponsored by Peking University. Started Sep 2017; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03289026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03289026.